Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Oncotarget(2022)10.18632/oncotarget.28258Source: DataRank Database

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma is a research paper published in Oncotarget (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.27)OA: goldTopics (35)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Zainul S. Hasanali ORCID,August Stuart,Sara Shimko,Kamal Sharma ORCID,Violetta V. Leshchenko ORCID

Live enrichment

PubMed:36093297 OpenAlex:https://openalex.org/W4292186328

National Institutes of Health

Grant: 1ZIABC010411-19

Initiation of DNA Replication in Mammalian Cells

National Institutes of Health

Grant: 5K12CA132783-08

Paul Calabresi Career Development Award for Clinical Oncology (K12)

National Institutes of Health

Grant: 5R01CA098472-13

Survival Mechanisms in Leukemic NK Cells

FWCI

0.27

Citation Percentile

0.5%

Citation Trend

2024

goldLicense: cc-by

journalhttps://www.oncotarget.com/article/28258/pdf/

publisherhttps://www.oncotarget.com/article/28258/pdf/

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.28258

journalhttps://doi.org/10.18632/oncotarget.28258

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36093297

Fields of Study

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentUbiquitin and proteasome pathways0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

RituximabVorinostatAdultHumansImmunologic FactorsImmunotherapyNeoplasm Recurrence, LocalCladribineAntigens, CD20Lymphoma, Mantle-CellEpigenesis, Genetic

Keywords

MedicineCancerGerontologyLibrary scienceFamily medicineInternal medicineAdultVorinostatLymphoma, Mantle-CellAntigens, CD20Epigenesis, GeneticCladribineHumansImmunologic FactorsImmunotherapyNeoplasm Recurrence, LocalRituximabResearch Paper

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being